Sanara MedTech Insider Taylor B Files Form 4, No Transaction Data

TL;DR

**Insider Taylor B filed a Form 4 for Sanara MedTech, but it's a placeholder with no actual trades reported.**

AI Summary

This Form 4 filing indicates that Taylor Elizabeth B, an insider at Sanara MedTech Inc., reported changes in her beneficial ownership of the company's securities. While the filing details the reporting person and the issuer, it does not contain specific transaction data like share purchases or sales, or dollar amounts. This matters to investors because Form 4s typically disclose insider trading activity, which can signal management's confidence (or lack thereof) in the company's future, but this particular filing is a placeholder without transaction specifics.

Why It Matters

This filing is a standard disclosure that an insider has reported, but without transaction details, it doesn't provide immediate insight into insider buying or selling activity, which can influence stock perception.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of an insider's reporting obligation and does not contain information that directly impacts the company's financial health or operational risks.

Analyst Insight

Investors should monitor subsequent Form 4 filings from Taylor Elizabeth B for Sanara MedTech Inc. to identify actual insider trading activity, as this specific filing lacks transaction details.

Key Players & Entities

• Taylor Elizabeth B (person) — Reporting Person
• Sanara MedTech Inc. (company) — Issuer
• 0002052808 (person) — CIK of Taylor Elizabeth B
• 0000714256 (company) — CIK of Sanara MedTech Inc.

FAQ

Filing Documents

• ownership.html (4)
• ownership.xml (4) — 4KB
• 0001493152-26-012180.txt ( ) — 5KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Taylor Elizabeth B (Last) (First) (Middle) 1200 SUMMIT AVE SUITE 414 (Street) FORT WORTH TEXAS 76102 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol Sanara MedTech Inc. [ SMTI ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Financial Officer 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/22/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/22/2026 A 12,687 (1) D $ 0 (1) 17,632 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date. /s/ Elizabeth B. Taylor 03/23/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR